Bio-Connect
IHC-P analysis of human tonsil tissue section using GTX02590 Annexin A1 antibody [ANXA1/3869R].
IHC-P analysis of human tonsil tissue section using GTX02590 Annexin A1 antibody [ANXA1/3869R].
IHC-P analysis of human tonsil tissue section using GTX02590 Annexin A1 antibody [ANXA1/3869R].

Annexin A1 antibody [ANXA1/3869R]

Research Use Only
GTX02590
GeneTex
ApplicationsImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse
TargetANXA1
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Annexin A1 antibody [ANXA1/3869R]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1-2 microg/ml. IHC-P: 1-2 microg/ml. IP: 2-4 microg/mg protein. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    ANXA1/3869R
  • Concentration
    200 ug/ml
  • Conjugate
    Unconjugated
  • Formulation
    Liquid
  • Gene ID301
  • Target name
    ANXA1
  • Target description
    annexin A1
  • Target synonyms
    annexin A1; annexin I (lipocortin I); annexin-1; ANX1; calpactin II; calpactin-2; chromobindin-9; epididymis secretory sperm binding protein; LPC1; phospholipase A2 inhibitory protein
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP04083
  • Protein Name
    Annexin A1
  • Scientific Description
    This gene encodes a membrane-localized protein that binds phospholipids. This protein inhibits phospholipase A2 and has anti-inflammatory activity. Loss of function or expression of this gene has been detected in multiple tumors. [provided by RefSeq, Dec 2014]
  • Reactivity
    Human, Mouse
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Antibody-activated trans-endothelial delivery of mesoporous organosilica nanomedicine augments tumor extravasation and anti-cancer immunotherapy. Huang T et al., 2021 Jul, Bioact Mater
    Read more